Dive Brief: A federal jury on Tuesday awarded Insulet $452 million in its patent skirmish with EOFlow over insulin patch pumps. The jury awarded Insulet
The Food and Drug Administration issued a much-anticipated update on Tuesday detailing how it plans to regulate changes to artificial intelligence-enabled medical devices after the
Dive Brief: GE Healthcare will acquire Nihon Medi-Physics (NMP), a Tokyo-based radiopharmaceutical firm, by buying the remaining 50% stake from parent Sumitomo Chemical, the companies
Dive Brief: Embecta said Tuesday that it will cancel its insulin patch pump program just months after receiving clearance from the Food and Drug Administration
Dive Brief: Boston Scientific said Monday it has agreed to acquire Intera Oncology, which makes treatments for liver tumors primarily caused by metastatic colorectal cancer.
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Identifeye Health, a startup looking to make
Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Sequel Medtech is working to sell a
Tempus AI agreed to buy genetic testing company Ambry Genetics for $375 million in cash and $225 million in shares. Chicago-based Tempus, which makes AI-enabled
As the U.S. presidential election looms, a final group of medtech companies will report earnings results, setting the tone for the remainder of the year.
Medtronic settled a lawsuit claiming its pulse oximeters may provide less accurate readings for people with darker skin pigmentation. Roots Community Health, based in Oakland,